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Abstract
Background: Multiple hereditary osteochondromatosis is characterized by the growth of benign 
cartilaginous tumors in the form of exostosis, mainly in the metaphysis of long bones. A preva-
lence of 1/50,000 individuals has been documented for this disease.
Case reports: This article presents the clinical information and the autosomal dominant inherit-
ance pattern where exostosin genes (EXT gene family) were affected in three members of a 
family with multiple hereditary osteochondromatosis. The three patients showed limitation in 
the range of motion of wrists, shoulders and ankles. Clinical diagnosis was confirmed with radi-
ology and malignancy was ruled out in all patients.
Conclusions: This disease requires frequent medical evaluation, surgical bone correction when 
the function is affected, surveillance for malignant transformation, and genetic counseling.
© 2016 Hospital Infantil de México Federico Gómez. Published by Masson Doyma México S.A. 
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1. Introduction
Multiple hereditary osteochondromatosis (MHO) has several 
synonyms: multiple cartilaginous exostoses, hereditary multi-
ple exostosis, congenital osteochondromatosis, familial osteo-
chondromatosis, hereditary osteochondromatosis, hereditary 
deforming chondrodysplasia and diaphysial aclasis.1 MHO is an 
autosomal dominant condition characterized by the growth of 
multiple benign tumors called osteochondromas. These os-
teochondromas are cartilage-capped bone tumors growing 
outward from the metaphysis of long bones, and their num-
ber may range from two to hundreds.2 MHO is caused by a 
defect in metaphyseal osteoclast activity during the remod-
eling process in childhood and early adolescence. During skel-
etal development, ostechondromas enlarge and gradually 
ossify. They stop growing with skeletal maturity after which 
no new osteochondroma development is observed.1 Tumors 
are metaphyseal bony protuberances coated by cartilage.
MHO was first described in 1839 by John Hunter in his 
book “Lectures on the Principles of Surgery”3 and reported 
prevalence is 1/50,000.4-6 Nowadays, exostosin genes (EXT 
gene family) are known to express glycoproteins involved in 
chondrocyte transportation, proliferation and differentia-
tion.7 The gene EXT1 is located in the chromosome 8q24, 
where 44-66% of mutations responsible of MHO occur. The 
gene EXT2 is located in the chromosome 11p11-p12. This 
gene may be altered by up to 30% mutations. The gene EXT3 
is located in the chromosome 19p and mutations in this gene 
may be the cause of some cases of MHO.8
The mean age for diagnosis of MHO is three years and 96% 
of cases are diagnosed before 12 years of age.4 Osteochon-
dromas usually develop during the time of natural bone 
growth.9 They arise from the displacement of the lateral 
side of the growth plate in a direction diagonal to the long 
axis of the bone and away from the adjacent joint; in conse-
quence, they usually are mushroom shaped and size from 
one to 20 cm. The outer layer of the osteochondroma head 
is made of hyaline benign cartilage of variable thickness and 
limited by perichondrium.10 Osteochondromas can produce 
shortening of the limbs, scoliosis, pathological fractures and 
pseudarthrosis, bilateral coxa valga, progressive widening of 
the proximal femoral metaphysis, shortening of the ulna 
with radial deformation and radio-humeral subluxation, val-
gus deformation of the knees and ankles, and decreased 
stature due to deformations and angulations.11,12
Osteochondromas are localized mainly in long bones, 
such as proximal humerus, distal and proximal femur, tibia 
and fibula; however, they may also affect the spine, pelvis, 
ribs and scapulas.13,14.
The deformations most commonly identified are bilateral 
coxa valga, progressive widening of the femoral proximal 
metaphysis, ulnar shortening with radial deformation, radio-
humeral subluxation, knee and ankle valgus and shortened 
stature due to deformations and bowing. However, the most 
common presentation is painless increase in volume, or a 
slow growing tumor.2 Pain and motor deficits are secondary 
to the mechanical block. The most feared complication is 
the development of chondrosarcoma, which occurs up to 
25% of cases.11
The imaging method of choice for evaluating the patient 
with osteochondromas is plain radiography. Generally, the 
film shows an excrescence, either pedunculated or sessile, 
with well-defined margins arising from the metaphysis and 
away from the epiphysis.2 Ocasionally, a widening of the 
metaphysis is observed. Some osteochondromas arising from 
the surface of the bone contain cortex and spongy bone, 
and appear to be a continuation of the original bone.15
The aim of this study was to characterize MHO in three 
members of a family, to describe the observed inheritance 
pattern, and to provide genetic counseling.
2. Clinical cases
Three related cases of MHO were diagnosed. The mother 
had a de novo mutation which she transmitted to her chil-
Osteocondromatosis múltiple hereditaria en una familia
Resumen
Introducción. La osteocondromatosis múltiple hereditaria se caracteriza por el crecimiento de 
múltiples tumores benignos, cartilaginosos, que crecen en forma de exostosis predominante-
mente en las metáfisis de los huesos largos. Se ha descrito una prevalencia de 1/50,000 indivi-
duos.
Casos clínicos. Se presenta la información clínica y patrón hereditario autosómico dominante, en 
el que están afectados los genes de exostosina (familia de genes EXT) en tres miembros de una 
familia con osteocondromatosis múltiple. Los tres pacientes han presentado alteraciones en los 
arcos de movimiento de muñecas, hombros o tobillo. El diagnóstico clínico fue confirmado con 
estudios radiológicos y no hay evidencia de que las lesiones se hayan malignizado.
Conclusiones. Esta entidad requiere de supervisión periódica, corrección quirúrgica de las de-
formaciones que limiten la función, vigilancia de la transformación maligna y consejería gené-
tica.
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dren in an autosomal dominant pattern (Figure 1). The chil-
dren’s father did not show apparent osteoarticular problems, 
but had a history of hypothyroidism, and he was on replace-
ment therapy with levothyroxine.
2.1. Case 1 (II2)
Female patient, 40 years old; since birth, her parents noted 
articular cracks when they up loaded her although with no 
apparent pain. At 3 years of age, a disabling lump was de-
tected in the left knee which was painful when walking and 
required surgery. At age 16, she developed painful deformi-
ties in the ankles (in the external malleolus of 4 x 4 x 3 cm 
and in the tibia), so she needed corrective surgery. At age 
20, she presented thickening and deformity of the wrists 
measuring 4 x 5 x 2 cm. At the end of bone growth, it was 
found that the length of the right arm was 2 cm greater than 
the left one (Figure 2).
2.2. Case 2 (III1)
A 12-year-old male patient with a history of subclinical hypo-
thyroidism in the first year of life which did not require 
treatment. Osteochondromas were noticeable at 2 years of 
age causing ankle deformities with no fractures. Afterwards, 
new tumors have aroused in the shoulder, tibia, wrist and 
femur. He presented limited motion in the wrist and shoul-
der with occasional pain. His growth has been satisfactory, 
with height in the 50th percentile and without shortening of 
the lower limbs (Figure 3).
2.3. Case 3 (III2)
An 8-year-old male patient, diagnosed with subclinical hypo-
thyroidism from 8 months to 2.5 years of age which normal-
ized later. MHO diagnosis was established at 2 years of age 
because of humeral and wrist tumors. His growth has been 
satisfactory, without shortening of the lower limbs, as well 
as weight and height in the 50th percentile. He has limited 
motion in wrists and shoulders with sporadic pain during 
certain movements (Figure 4).
Multiple bone lesions were identified in radiographs, with 
osteochondromas in metaphysis and epiphysis of long, short 
and flat bones, of different sizes and shapes, usually with a 
sessile image of broad base, covered with cortical bone and 
“mushroom head” shaped cap (IV-V) (Figures 2-4).
3. Discussion
The loss of both alleles of the EXT1 gene has been linked to 
osteochondromas, suggesting a loss of tumor suppressor ac-
tivity mechanism.8,16 EXTL1, EXTL2 and EXTL3 conform an-
other EXT gene family associated to the MHO, and are 
considered homologous to EXT1 and EXT2 genes. Heparan 
sulfate is one of the proteins altered by the lack of process-
ing. In a study of 36 Chinese families it was found that muta-
tions in EXT2 reached 33% whereas in EXT1 reached 14%. 
The predominant types of mutations were changes of the 
reading frame and nonsense mutations (80%). These muta-
tions may produce premature termination codons, and 
hence incomplete non-functional protein. This study shows 
that the pattern of mutations can vary among different pop-
ulations.17 According to Wuyts et al., penetrance is 96% 
among women and 100% in men.1 The affected person has a 
50% chance of passing the trait to the offspring.
Regarding differential diagnosis, among the syndromes 
resulting from the mutation of EXT genes there is the 
Langer-Giedion syndrome in which there are exostosis, men-
tal retardation, malformations in skull and distal extremi-
ties. In Potocki-Shafferse syndrome there are craniofacial 
abnormalities, mental retardation and epiphyseal exostosis 
affecting only one side of the body.18 In hemimelic epiphy-
































Figure 1 Family tree. The mother and two sons are cases of multiple hereditary osteochondromatosis.
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causing focal growth of the medial and lateral portions of 
the epiphysis, with unilateral distribution. This dysplasia 
most often affects the carpus, tarsus, and lower limbs.19 In 
contrast, in osteosarcoma, the injuries are usually located in 
metaphysis of long bones and knees; in radiographs bone 
erosions are observed in cortical and medullary regions, 
with poorly defined edges and invasion of soft structures.20
One of the most serious complications of ostoechondro-
mas is their malignant transformation (chondrosarcoma). 
However, there are not specific guidelines for screening. 
The warning signs for malignant transformation are growth 
with irregular margins, presence of a mass of soft tissue at-
tached to the tumor, pain, bone erosion and diffuse calcifi-
cation with an irregular pattern. Radiological warning signs 
are radiolucent round nodular lesions or with a pattern in 
rings.21 In later stages, erosions of the endothelial cortex 
may be found. None of the cases presented in this study 
showed suspicious signs of malignant transformation.
Nowadays, the treatment to achieve better effectiveness 
and better results is surgery. This is reserved for those pa-
tients who are symptomatic and/or have deformities caused 
by osteochondromas. The procedures performed include tu-
mor excision, corrective osteotomy, procedures to align or 
enlarge bone length, epiphysiodesis and hemiepiphysiode-
sis.21-24 Of the three members of the family described, II2 was 
the only case that has required multiple palliative surgeries 
Figure 2 Case 1 (II2). A 40-year-old female patient (mother) with exostosis in the first sternocostal joints and in the upper part of 
the posterior portion of the rib (a), bony protrusions in femoral necks and intertrochanteric zone with bone deformity (b), exostosis 
in proximal humerus (c) and distal third of posteromedial zone of both femurs and in the posterolateral region of the left tibia (d).
Figure 3 Case 2 (III1). A 12-year-old male patient with exostosis in the neck and proximal third of the humerus, in the anterior 
portion of the fifth rib (a), in the anterolateral zone of both ulnas, suggesting a type III deformity of the Masada classification (b), 
femur distal third with meta-diaphysial widening (c), and lumps in the anterolateral region of the right tibia and ulna, which 
increased in size the following year (d, e).
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for pain relief or function restoration (conservation of limb 
range of motion).
MHO is inherited in an autosomal dominant pattern and 
is genetically heterogeneous. In about 90% of affected pa-
tients, germline mutations of the tumor suppressor genes 
EXT1 or EXT2 have been found. Diagnosis is established 
clinically and radiologically. Genetic counseling was of-
fered to the family in order to inform on the risk of recur-
rence and clinical implications of this disease, to help 
them make informed medical and personal decisions, and 
to provide timely and adequate follow-up. Genetic coun-
seling is provided for those families to have information 
on the nature, inheritance, and the implications of this 
condition.
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